Troubling news from Asia about treating enteric fever: a coming storm

In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Ryan, Edward T
التنسيق: Technical Report
اللغة:en_US
منشور في: Lancet Infect Dis 2016 2016
الموضوعات:
الوصول للمادة أونلاين:http://103.69.126.140:8080/handle/123456789/817
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
id oai:103.69.126.140:123456789-817
record_format dspace
spelling oai:103.69.126.140:123456789-8172022-11-09T06:51:34Z Troubling news from Asia about treating enteric fever: a coming storm Ryan, Edward T Enteric Fever: In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should no longer be recommended as front-line empirical treatment for individuals with enteric fever in Nepal. Second, a large proportion of individuals in Nepal who are syndromically characterised as having uncomplicated enteric fever probably have an alternative diagnosis. 2016-01-28T20:10:36Z 2022-11-08T10:23:58Z 2016-01-28T20:10:36Z 2022-11-08T10:23:58Z 2016-01-19 Technical Report http://103.69.126.140:8080/handle/123456789/817 en_US application/pdf Lancet Infect Dis 2016
institution My University
collection DSpace
language en_US
topic Enteric Fever:
spellingShingle Enteric Fever:
Ryan, Edward T
Troubling news from Asia about treating enteric fever: a coming storm
description In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should no longer be recommended as front-line empirical treatment for individuals with enteric fever in Nepal. Second, a large proportion of individuals in Nepal who are syndromically characterised as having uncomplicated enteric fever probably have an alternative diagnosis.
format Technical Report
author Ryan, Edward T
author_facet Ryan, Edward T
author_sort Ryan, Edward T
title Troubling news from Asia about treating enteric fever: a coming storm
title_short Troubling news from Asia about treating enteric fever: a coming storm
title_full Troubling news from Asia about treating enteric fever: a coming storm
title_fullStr Troubling news from Asia about treating enteric fever: a coming storm
title_full_unstemmed Troubling news from Asia about treating enteric fever: a coming storm
title_sort troubling news from asia about treating enteric fever: a coming storm
publisher Lancet Infect Dis 2016
publishDate 2016
url http://103.69.126.140:8080/handle/123456789/817
work_keys_str_mv AT ryanedwardt troublingnewsfromasiaabouttreatingentericfeveracomingstorm
_version_ 1761501188200595456